JP2025535192A5 - - Google Patents
Info
- Publication number
- JP2025535192A5 JP2025535192A5 JP2025542435A JP2025542435A JP2025535192A5 JP 2025535192 A5 JP2025535192 A5 JP 2025535192A5 JP 2025542435 A JP2025542435 A JP 2025542435A JP 2025542435 A JP2025542435 A JP 2025542435A JP 2025535192 A5 JP2025535192 A5 JP 2025535192A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- antigen
- lilrb1
- lilrb2
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2214614.6A GB202214614D0 (en) | 2022-10-04 | 2022-10-04 | Compositions and methods for modulation of macrophage |
| GB2214614.6 | 2022-10-04 | ||
| PCT/GB2023/050592 WO2023170434A1 (en) | 2022-03-11 | 2023-03-13 | Compositions and methods for modulation of macrophage activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025535192A JP2025535192A (ja) | 2025-10-22 |
| JP2025535192A5 true JP2025535192A5 (enExample) | 2026-03-24 |
Family
ID=84000149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025542435A Pending JP2025535192A (ja) | 2022-10-04 | 2023-03-13 | マクロファージ活性の調整のための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JP2025535192A (enExample) |
| KR (1) | KR20250096720A (enExample) |
| CN (1) | CN120435496A (enExample) |
| AU (1) | AU2023232991A1 (enExample) |
| CR (1) | CR20250172A (enExample) |
| GB (1) | GB202214614D0 (enExample) |
| IL (1) | IL319958A (enExample) |
| MX (1) | MX2025003929A (enExample) |
-
2022
- 2022-10-04 GB GBGB2214614.6A patent/GB202214614D0/en not_active Ceased
-
2023
- 2023-03-13 AU AU2023232991A patent/AU2023232991A1/en active Pending
- 2023-03-13 CR CR20250172A patent/CR20250172A/es unknown
- 2023-03-13 KR KR1020257014592A patent/KR20250096720A/ko active Pending
- 2023-03-13 JP JP2025542435A patent/JP2025535192A/ja active Pending
- 2023-03-13 CN CN202380079852.1A patent/CN120435496A/zh active Pending
- 2023-03-13 IL IL319958A patent/IL319958A/en unknown
-
2025
- 2025-04-02 MX MX2025003929A patent/MX2025003929A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103260646B (zh) | Notum蛋白调节剂和使用方法 | |
| JP7209464B2 (ja) | ヒトインターロイキン－２に対する免疫刺激性モノクローナル抗体 | |
| CN112969476B (zh) | 多特异性蛋白分子 | |
| JP2020534830A5 (enExample) | ||
| JP2022509930A (ja) | 抗ｃｄ７３抗体、その抗原結合フラグメントおよびそれらの使用 | |
| CN108084265B (zh) | 特异性结合人的5t4抗原的全人源单域抗体及其应用 | |
| JP2021511811A5 (enExample) | ||
| JP2017538439A5 (enExample) | ||
| JP2013544493A5 (enExample) | ||
| JP2020501598A5 (enExample) | ||
| CN105209493A (zh) | 用于诊断和治疗用途的her3特异性单克隆抗体 | |
| IL273196B1 (en) | Claudin 6 antibodies and methods of cancer treatment | |
| JP2016526904A5 (enExample) | ||
| JP2023527937A5 (enExample) | ||
| CN112574308A (zh) | 靶向bcma的抗体、双特异性抗体及其用途 | |
| JP2017521054A5 (enExample) | ||
| JP2021516051A5 (enExample) | ||
| CN108164600B (zh) | 一种抗gpc3抗体及其制备方法和用途 | |
| CN112940124A (zh) | 靶向Claudin18.2的人源化单克隆抗体及其制备方法和应用 | |
| WO2014068300A1 (en) | Anti-s100a4 antibody molecules and their uses | |
| JP2020037571A (ja) | Ｔｍｃｃ３の阻害による、癌を抑制するための方法 | |
| CN106749667A (zh) | 一种抗癌胚抗原的纳米抗体及其应用 | |
| JP2025514636A5 (enExample) | ||
| JP2018528759A5 (enExample) | ||
| WO2023071676A1 (zh) | 一种抗her2/抗pd-l1双功能抗体及其应用 |